Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Sign Up
Sign Up
Markets
/
Stocks
/
nasdaq-carl
/
Carlsmed Ord Shs
CARL
13.230
USD
0.000
0.00%
Close 01/27, 16:00(ET)
Quotes delayed by 15 min
13.230
USD
+13.230
After-hours (ET)
351.71M
Market Cap
--
P/E TTM
Carlsmed Ord Shs
13.230
0.000
0.00%
Overview
Company
Financials
Analysis
Overview
Company
Financials
Analysis
More Details of Company
Carlsmed Ord Shs Info
Ticker Symbol
- -
Company name
- -
IPO date
- -
CEO
- -
Number of employees
- -
Security type
- -
Fiscal year-end
- -
Address
- -
City
- -
Stock exchange
- -
Country
- -
Postal code
- -
Phone
- -
Website
- -
Ticker Symbol
- -
IPO date
- -
CEO
- -
Company Executives of Carlsmed Ord Shs
Name
Name/Position
Position
Shareholding
Change
Mr. Michael (Mike) Cordonnier
Mr. Michael (Mike) Cordonnier
Chairman of the Board, President, Chief Executive Officer, Co-Founder
Chairman of the Board, President, Chief Executive Officer, Co-Founder
1.24M
+1239330.00%
Mr. Niall Casey, J.D.
Mr. Niall Casey, J.D.
Co-Founder, Director, Chief Intellectual Property Officer
Co-Founder, Director, Chief Intellectual Property Officer
941.20K
+941197.00%
Dr. Jonathan D. (Jon) Root, M.D.
Dr. Jonathan D. (Jon) Root, M.D.
Independent Director
Independent Director
484.00K
+483999.00%
Mr. Kevin C. O'Boyle
Mr. Kevin C. O'Boyle
Independent Director
Independent Director
17.33K
+17333.00%
Mr. Leonard (Leo) Greenstein
Mr. Leonard (Leo) Greenstein
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
--
--
Mr. William (Scott) Durall
Mr. William (Scott) Durall
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Robert E. Mittendorff, M.D.
Mr. Robert E. Mittendorff, M.D.
Independent Director
Independent Director
--
--
Mr. Philip (Phil) Young
Mr. Philip (Phil) Young
Independent Director
Independent Director
--
--
Mr. Kevin K. Sidow
Mr. Kevin K. Sidow
Independent Director
Independent Director
--
--
Ms. Jenifer Kamocsay
Ms. Jenifer Kamocsay
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Michael (Mike) Cordonnier
Mr. Michael (Mike) Cordonnier
Chairman of the Board, President, Chief Executive Officer, Co-Founder
Chairman of the Board, President, Chief Executive Officer, Co-Founder
1.24M
+1239330.00%
Mr. Niall Casey, J.D.
Mr. Niall Casey, J.D.
Co-Founder, Director, Chief Intellectual Property Officer
Co-Founder, Director, Chief Intellectual Property Officer
941.20K
+941197.00%
Dr. Jonathan D. (Jon) Root, M.D.
Dr. Jonathan D. (Jon) Root, M.D.
Independent Director
Independent Director
484.00K
+483999.00%
Mr. Kevin C. O'Boyle
Mr. Kevin C. O'Boyle
Independent Director
Independent Director
17.33K
+17333.00%
Mr. Leonard (Leo) Greenstein
Mr. Leonard (Leo) Greenstein
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
--
--
Mr. William (Scott) Durall
Mr. William (Scott) Durall
Chief Commercial Officer
Chief Commercial Officer
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Wed, Dec 10
Updated: Wed, Dec 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
B Capital Group Management LP
31.29%
U.S. Venture Partners
21.22%
OrbiMed Advisors, LLC
4.71%
Cordonnier (Michael)
4.66%
Janus Henderson Investors
4.11%
Other
34.01%
Shareholders
Shareholders
Proportion
B Capital Group Management LP
31.29%
U.S. Venture Partners
21.22%
OrbiMed Advisors, LLC
4.71%
Cordonnier (Michael)
4.66%
Janus Henderson Investors
4.11%
Other
34.01%
Shareholder Types
Shareholders
Proportion
Corporation
31.29%
Venture Capital
21.22%
Individual Investor
11.54%
Investment Advisor/Hedge Fund
5.36%
Private Equity
4.71%
Investment Advisor
4.03%
Hedge Fund
2.55%
Pension Fund
0.67%
Research Firm
0.14%
Other
18.49%
Institutional Shareholding
Updated: Wed, Jan 21
Updated: Wed, Jan 21
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q4
72
10.32M
3.80%
--
2025Q4
72
10.32M
38.81%
+9.31M
2025Q3
68
10.32M
38.80%
+9.32M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
B Capital Group Management LP
8.32M
31.29%
--
--
Sep 30, 2025
U.S. Venture Partners
5.64M
21.22%
+5.64M
--
Jul 24, 2025
OrbiMed Advisors, LLC
1.25M
4.71%
+400.74K
+47.04%
Sep 30, 2025
Cordonnier (Michael)
1.24M
4.66%
+1.24M
--
Jul 24, 2025
Janus Henderson Investors
1.09M
4.11%
+1.09M
--
Sep 30, 2025
Casey (Niall)
941.20K
3.54%
+941.20K
--
Jul 24, 2025
Root (Jonathan D)
484.00K
1.82%
+484.00K
--
Jul 24, 2025
BlackRock Institutional Trust Company, N.A.
355.10K
1.34%
+355.10K
--
Sep 30, 2025
Avidity Partners Management LP
321.91K
1.21%
+321.91K
--
Sep 30, 2025
The Vanguard Group, Inc.
227.19K
0.85%
+115.83K
+104.01%
Sep 30, 2025
View more
Related ETFs
Updated: Tue, Dec 9
Updated: Tue, Dec 9
Name
Proportion
iShares Micro-Cap ETF
0.02%
ProShares UltraPro Russell2000
0%
Proshares Ultra Russell 2000
0%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 ETF
0%
iShares Russell 2000 Growth ETF
0%
iShares Russell 2000 Value ETF
0%
Global X Russell 2000 ETF
0%
iShares Micro-Cap ETF
Proportion
0.02%
ProShares UltraPro Russell2000
Proportion
0%
Proshares Ultra Russell 2000
Proportion
0%
ProShares Hedge Replication ETF
Proportion
0%
iShares Russell 2000 ETF
Proportion
0%
iShares Russell 2000 Growth ETF
Proportion
0%
iShares Russell 2000 Value ETF
Proportion
0%
Global X Russell 2000 ETF
Proportion
0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI
Please log in to use KeyAI
Log in
Sign Up